- Home
- GNRC vs RGEN Comparison
GNRC vs RGEN Comparison
Compare GNRC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNRC
- RGEN
- Stock Information
- Founded
- GNRC 1959
- RGEN 1981
- Country
- GNRC United States
- RGEN United States
- Employees
- GNRC N/A
- RGEN N/A
- Industry
- GNRC Metal Fabrications
- RGEN Medical/Dental Instruments
- Sector
- GNRC Consumer Discretionary
- RGEN Health Care
- Exchange
- GNRC Nasdaq
- RGEN Nasdaq
- Market Cap
- GNRC 10.9B
- RGEN 7.6B
- IPO Year
- GNRC 2010
- RGEN N/A
- Fundamental
- Price
- GNRC $160.54
- RGEN $156.55
- Analyst Decision
- GNRC Buy
- RGEN Buy
- Analyst Count
- GNRC 20
- RGEN 12
- Target Price
- GNRC $177.78
- RGEN $187.44
- AVG Volume (30 Days)
- GNRC 665.9K
- RGEN 470.1K
- Earning Date
- GNRC 02-12-2025
- RGEN 02-19-2025
- Dividend Yield
- GNRC N/A
- RGEN N/A
- EPS Growth
- GNRC 89.80
- RGEN N/A
- EPS
- GNRC 4.82
- RGEN N/A
- Revenue
- GNRC $4,124,703,000.00
- RGEN $633,513,000.00
- Revenue This Year
- GNRC $9.21
- RGEN $2.28
- Revenue Next Year
- GNRC $8.29
- RGEN $9.88
- P/E Ratio
- GNRC $33.32
- RGEN N/A
- Revenue Growth
- GNRC 2.91
- RGEN N/A
- 52 Week Low
- GNRC $108.89
- RGEN $113.50
- 52 Week High
- GNRC $195.94
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- GNRC 44.08
- RGEN 60.07
- Support Level
- GNRC $153.25
- RGEN $149.15
- Resistance Level
- GNRC $162.17
- RGEN $160.64
- Average True Range (ATR)
- GNRC 3.93
- RGEN 5.96
- MACD
- GNRC 1.06
- RGEN 0.91
- Stochastic Oscillator
- GNRC 76.61
- RGEN 79.57
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.